Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1

Registration statement for face-amount certificate companies

Registration Statements
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML